0001950047-24-006960.txt : 20240911 0001950047-24-006960.hdr.sgml : 20240911 20240911161927 ACCESSION NUMBER: 0001950047-24-006960 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240911 DATE AS OF CHANGE: 20240911 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 241292867 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Fordyce Marshall CENTRAL INDEX KEY: 0001859453 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O VERA THERAPEUTICS, INC. STREET 2: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 144 1 primary_doc.xml 144 0001859453 XXXXXXXX LIVE 0001831828 VERA THERAPEUTICS INC CL A 001-40407 8000 Marina Boulevard, Suite 120 Brisbane CA 94005 6507700077 MARSHALL FORDYCE Director Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

31250 1173437.50 54827665 09/11/2024 NASDAQ Common 09/11/2024 Exercise of Stock Options Issuer N 31250 09/11/2024 Cash N 10b5-1 Sales for MARSHALL FORDYCE

8000 Marina Boulevard, Suite 120 Brisbane CA 94005

COMMON 08/28/2024 30320 1117141.09 10b5-1 Sales for MARSHALL FORDYCE

8000 Marina Boulevard, Suite 120 Brisbane CA 94005

COMMON 08/14/2024 15625 586926.56 The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale. 09/11/2024 04/23/2024 /s/ Marshall Fordyce